EB UtrechtResearch BV
Utrecht, Netherlands
NCT Number: NCT05676385
This study assesses the glycemic responses to several nutritional products.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Utrecht, Netherlands
During a study visit fasted subjects will consume one serving of the reference product or of the test products. Venous blood samples will be taken at baseline and at several time-points over a 6-hr period.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fasted intake of First concept product (randomised)
Fasted intake Second concept product (randomised)
Fasted intake of Reference product (randomised)
Time frame: 6 hours
The decline in glucose (mmol/hour) after reaching peak glucose levels (Cmax) until reaching baseline (t = -5) blood glucose levels or, in case baseline blood glucose levels are not reached, the lowest observed blood glucose level.
Time frame: 6 hours
Incremental Area Under the Curve (iAUC) for glucose (mmol/L/hrs)
Time frame: 6 hours
Incremental Area Under the Curve (iAUC) for insulin (pmol/L/hrs)
Time frame: 6 hours
Incremental Area Under the Curve (iAUC) for paracetamol (pmol/L/hrs)
Time frame: 6 hours
Incremental peak levels (iCmax) of glucose (mmol/L)
Time frame: 6 hours
Incremental peak levels (iCmax) of insulin (pmol/L)
Time frame: 6 hours
Incremental peak levels (iCmax) of paracetamol (mg/L)
Time frame: 6 hours
Time to peak levels (Tmax) of glucose (min)
Time frame: 6 hours
Time to peak levels (Tmax) of insulin (min)
Time frame: 6 hours
Time to peak levels (Tmax) of paracetamol (min)
Nutricia Research
Industry
Acronym: EFFECT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05513404
Age-related Memory Disorders, Glucose Metabolism Disorders
Aberdeen, United Kingdom
View Trial DetailsNCT04836273
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Hellerup, Denmark
View Trial DetailsNCT04330196
Driving Impaired, Glucose Metabolism Disorders
Bern, Switzerland
View Trial DetailsNCT03984370
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Hellerup, Denmark
View Trial Details